3-deazaneplanocin has been researched along with Bone Loss, Osteoclastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Chen, Z; Han, S; He, W; Liang, Y; Ma, H; Qin, A; Rong, K; Xu, S; Yang, X; Zhao, J; Zhou, Y | 1 |
1 other study(ies) available for 3-deazaneplanocin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis.
Topics: Adenosine; Animals; Bone Resorption; Cell Differentiation; Epigenesis, Genetic; Mice; NF-kappa B; Osteoclasts; Osteogenesis; RANK Ligand | 2021 |